000 | 01954 a2200601 4500 | ||
---|---|---|---|
005 | 20250517163121.0 | ||
264 | 0 | _c20180404 | |
008 | 201804s 0 0 eng d | ||
022 | _a1475-2875 | ||
024 | 7 |
_a10.1186/s12936-017-1912-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHtun, Myo Win | |
245 | 0 | 0 |
_aChloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow. _h[electronic resource] |
260 |
_bMalaria journal _c07 2017 |
||
300 |
_a281 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntimalarials _xpharmacology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aChloroquine _xpharmacology |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDNA Copy Number Variations |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Flow |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMalaria, Vivax _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrosatellite Repeats _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
650 | 0 | 4 | _aMyanmar |
650 | 0 | 4 |
_aPlasmodium vivax _xdrug effects |
650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aMon, Nan Cho Nwe | |
700 | 1 | _aAye, Khin Myo | |
700 | 1 | _aHlaing, Chan Myae | |
700 | 1 | _aKyaw, Myat Phone | |
700 | 1 | _aHandayuni, Irene | |
700 | 1 | _aTrimarsanto, Hidayat | |
700 | 1 | _aBustos, Dorina | |
700 | 1 | _aRingwald, Pascal | |
700 | 1 | _aPrice, Ric N | |
700 | 1 | _aAuburn, Sarah | |
700 | 1 | _aThriemer, Kamala | |
773 | 0 |
_tMalaria journal _gvol. 16 _gno. 1 _gp. 281 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-017-1912-y _zAvailable from publisher's website |
999 |
_c27354024 _d27354024 |